» Articles » PMID: 25505859

Lipoprotein (a) and Atherogenic Indices in Sudanese Patients with Type 2 Diabetes

Overview
Specialty General Medicine
Date 2014 Dec 16
PMID 25505859
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Type 2 diabetes is associated with significant cardiac morbidity and mortality with a more than threefold increased risk of coronary artery disease (CAD). We aimed to assess the serum concentrations of lipoprotein (a) and lipid profile indexes as predictors for CAD in Sudanese type 2 diabetics compared to healthy subjects.

Materials & Methods: This case-control study was conducted at Jabir Abu-Aliz Specialized Center, Khartoum State, Sudan. After overnight fasting, 4 ml blood samples were collected in plain vials through venous puncture from each subject. Lipid profile parameters were estimated by standard laboratory procedures. Serum lipoprotein (a) was measured by immunoturbidimetric method. Statistical analyses were performed using SPSS software (version 17).

Results: Compared to healthy controls, type 2 diabetics showed significantly higher serum lipids and lipoprotein fractions. The mean values of lipoprotein (a), TC: HDL-C (5.55±.8 vs. 3.89±.6) and LDL-C: HDL-C (3.80±0.7 vs. 2.32±0.5) were significantly increased in patients. Lipoprotein (a) was significantly correlated with TG (p=.025), HDL-C (inversely, p<.001), VLDL-C (p= .025), and TC: HDL-C ratio (p= 016). Moreover, LDL-C: HDL-C ratio and TC were the most common risk factors distributed among the study patients (80% and 71.4% respectively).

Conclusion: Diabetic patients characterized by higher ratios of TC: HDL -C and LDL: HDL and Lipoprotein (a) compared to healthy controls. The evaluation of these lipid indices in diabetics, beside the routine lipid profile analysis, may be a crucial helpful step in the prevention of coronary artery disease since these atherogenic factors can be reduced by lifestyle modifications.

Citing Articles

Comparison of Multiple Equations for Low-Density Lipoprotein Cholesterol Calculation Against the Direct Homogeneous Method.

Alsadig R, Morsi A J Lipid Atheroscler. 2024; 13(3):348-357.

PMID: 39355402 PMC: 11439753. DOI: 10.12997/jla.2024.13.3.348.


Serum Lipoprotein (a) Levels in Black South African Type 2 Diabetes Mellitus Patients.

Joseph J, Ganjifrockwala F, George G Oxid Med Cell Longev. 2016; 2016:5743838.

PMID: 27833702 PMC: 5090092. DOI: 10.1155/2016/5743838.

References
1.
Schernthaner G . Is dyslipidaemia important if we control glycaemia?. Atheroscler Suppl. 2005; 6(3):3-10. DOI: 10.1016/j.atherosclerosissup.2005.06.001. View

2.
Bell D, Al Badarin F, OKeefe Jr J . Therapies for diabetic dyslipidaemia. Diabetes Obes Metab. 2011; 13(4):313-25. DOI: 10.1111/j.1463-1326.2010.01342.x. View

3.
van Hateren K, Landman G, Kleefstra N, Logtenberg S, Groenier K, Kamper A . The lipid profile and mortality risk in elderly type 2 diabetic patients: a ten-year follow-up study (ZODIAC-13). PLoS One. 2009; 4(12):e8464. PMC: 2795197. DOI: 10.1371/journal.pone.0008464. View

4.
Gaziano T, Bitton A, Anand S, Abrahams-Gessel S, Murphy A . Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010; 35(2):72-115. PMC: 2864143. DOI: 10.1016/j.cpcardiol.2009.10.002. View

5.
Di Bonito P, Moio N, Scilla C, Cavuto L, Sibilio G, Sanguigno E . Usefulness of the high triglyceride-to-HDL cholesterol ratio to identify cardiometabolic risk factors and preclinical signs of organ damage in outpatient children. Diabetes Care. 2011; 35(1):158-62. PMC: 3241301. DOI: 10.2337/dc11-1456. View